ILJIN SNT Co., Ltd. Announces Its Intention to Vote Against Aurinia Pharmaceuticals’s Revised Equity Incentive Plan Proposal

SEOUL, South Korea, June 7, 2024 /PRNewswire/ — Dear Fellow Shareholders, ILJIN SNT Co., Ltd. (“ILJIN”) is a long-standing investor of Aurinia Pharmaceuticals Inc. (“Aurinia” or the “Company”), and, together with its affiliates, currently holds more than 5% of Aurinia’s common stock. As…